Critical evaluation of vinflunine in the treatment of refractory metastatic urothelial carcinoma

Urothelial carcinoma (UC) accounts for 5% to 10% of malignancies in men in Europe and the United States. For locally advanced or metastatic disease, there are two standard firstline chemotherapy regimens: MVAC (methotrexate, vinblastine, doxorubicin, cisplatin) and gemcitabine/cisplatin. For refract...

Descripción completa

Detalles Bibliográficos
Autores principales: Morel, Armand, Talbot, Denis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819039/
https://www.ncbi.nlm.nih.gov/pubmed/24198619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819039/
https://www.ncbi.nlm.nih.gov/pubmed/24198619

Ejemplares similares